Application of a biphenyl polyphenol compound derived from natural plants in the preparation of a drug for treating herpetic diseases
Directly inactivate HSV by Caesappanin C, a biphenyl polyphenol compound from natural plant origin, solves the problems of low bioavailability and drug resistance of existing anti-HSV drugs, significantly inhibits HSV cell lesions and tissue damage, and has extensive treatment and prevention of HSV. Potential for infection.
CN118526483BActive Publication Date: 2024-11-26OCEAN UNIV OF CHINA
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CN202410792259.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-06-19
- Publication Date
- 2024-11-26
- Estimated Expiration
- 2044-06-19
AI Technical Summary
Technical Problem
Existing anti-HSV drugs such as acyclovir are low oral bioavailable, have short blood half-life, and cannot inhibit HSV reactivation. Long-term use may lead to the emergence of drug-resistant virus strains.
Method used
The natural plant-derived biphenyl polyphenol compound Caesappanin C was used to inhibit the proliferation of HSV in infected cells and the expression of viral proteins in infected cells by directly inactivating the virus, exerting anti-HSV effects.
Benefits of technology
Caesappanin C significantly inhibits the cytopathic response and tissue damage of HSV, improves the symptoms and survival rate of mice caused by HSV infection, and has broad market application prospects.
✦ Generated by Eureka AI based on patent content.
Smart Images

Figure CN118526483B_ABST
Abstract
The present invention provides an application of a natural plant-derived biphenyl polyphenol compound in the preparation of a drug for treating herpetic diseases, and belongs to the field of biomedical technology. The biphenyl polyphenol compound is Caesappanin C, which can significantly inhibit the proliferation of HSV in infected cells and the expression of viral proteins. The present invention conducts experiments by establishing a cell infection model, and the results show that Caesappanin C can significantly inhibit the in vitro proliferation of HSV, reduce the mRNA and protein expression levels of HSV, inhibit the formation of viral plaques, and exert an antiviral effect by directly interacting with the virus, and has higher activity and lower cytotoxicity, and a higher therapeutic index. The present invention shows through experiments that the plant-derived compound Caesappanin C can be used to prepare drugs for treating herpetic diseases.
Need to check novelty before this filing date? Find Prior Art
